mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |